Form CORRESP - Correspondence:
SEC Accession No. 0001867096-24-000116
Filing Date
2024-06-21
Accepted
2024-06-21 11:59:40
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9176
2 filename001.jpg GRAPHIC 168834
3 filename002.jpg GRAPHIC 238856
4 filename003.jpg GRAPHIC 223104
5 filename004.jpg GRAPHIC 57412
  Complete submission text file 0001867096-24-000116.txt   958098
Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Filer) CIK: 0001867096 (see all company filings)

EIN.: 871082097 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)